Location History:
- Marseille, FR (2018)
- Marseilles, FR (2019 - 2024)
Company Filing History:
Years Active: 2018-2024
Title: Cécile Bonnafous: Innovator in Cancer Treatment
Introduction
Cécile Bonnafous is a prominent inventor based in Marseilles, France. She has made significant contributions to the field of cancer treatment, particularly in the area of peripheral T cell lymphoma. With a total of 4 patents to her name, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Cécile's latest patents include a compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma. This invention relates to methods for the treatment, prevention, and diagnosis of this type of lymphoma using compounds that specifically bind KIR3DL2. Additionally, she has developed methods for the treatment of peripheral T cell lymphoma using compounds that bind NKp46. These compounds are designed to deplete tumor cells expressing NKp46 on their surface, and her work also includes the use of antibodies that specifically bind NKp46 in diagnostic and theranostic assays.
Career Highlights
Cécile Bonnafous is currently associated with Innate Pharma, a company dedicated to developing innovative immunotherapies for cancer treatment. Her research and inventions have significantly advanced the understanding and treatment of peripheral T cell lymphoma.
Collaborations
Cécile collaborates with notable colleagues such as Hélène Sicard and Renaud Buffet, contributing to a dynamic research environment focused on cancer therapies.
Conclusion
Cécile Bonnafous is a trailblazer in the field of cancer treatment, with her innovative patents and collaborative efforts making a substantial impact on the fight against peripheral T cell lymphoma. Her work exemplifies the importance of research and innovation in developing effective therapies for challenging medical conditions.